HYPOPARATHYROIDISM
Clinical trials for HYPOPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new HYPOPARATHYROIDISM trials appear
Sign up with your email to follow new studies for HYPOPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended trial tests Long-Term safety of new hormone disorder drug
Disease control OngoingThis study follows patients who completed a previous 12-week trial to check the long-term safety of MBX 2109, a weekly injection for hypoparathyroidism. It involves 60 adults with this hormone disorder who will continue treatment to monitor side effects and see if the drug helps …
Matched conditions: HYPOPARATHYROIDISM
Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC
-
Massive patient registry tracks rare hormone disorder treatment
Knowledge-focused OngoingThis study is a long-term registry that aims to understand the safety and effectiveness of a hormone replacement drug (rhPTH[1-84]) for people with chronic hypoparathyroidism. It will follow over 1,300 adults and children who are already receiving treatment as part of their norma…
Matched conditions: HYPOPARATHYROIDISM
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC